Daiichi Sankyo Co Ltd (4568.T)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|65||2010||Executive President, President, Chief Executive Officer, Representative Director|
|65||2015||Executive Vice President, Chief Director of General Affairs & Human Resources, Representative Director|
|64||2015||Executive Vice President, Chief Director of Administration, Representative Director|
|61||2015||Senior Managing Executive Officer, Director|
|65||2015||Senior Managing Executive Officer, President of Subsidiary, Director|
- BRIEF-Portola Pharmaceuticals expands pact with Daiichi Sankyo
- BRIEF-Pieris Pharmaceuticals to receive GLP Tox payment in Daiichi Sankyo collaboration
- BRIEF-Daiichi Sankyo Co and Inspirion Delivery Sciences LLC Announce U.S. Licensing Agreement for MorphaBond
- BRIEF-Daiichi Sankyo completes 20.2 mln shares' buy-back for 50 bln yen
- BRIEF-Daiichi Sankyo Co Ltd, Dana-Farber Cancer Institute today announce lung cancer research collaboration